Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The INSPiRe Programme: Developing an Intensive Suicide Prevention Therapy for Suicidal Prisoners

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03499548
Recruitment Status : Completed
First Posted : April 17, 2018
Last Update Posted : August 12, 2019
Sponsor:
Information provided by (Responsible Party):
Jessica Killilea, University of Manchester

Brief Summary:
This study aims to assess the acceptability and feasibility of a short-term, intensive Cognitive Behavioural Therapy (CBT) delivered to male prisoners who have thoughts of ending their lives.

Condition or disease Intervention/treatment Phase
Suicide Other: INSPiRe Programme Not Applicable

Detailed Description:
10 hours of an adapted CBT therapy for suicide will be delivered across 2 weeks in 5 2 hour sessions to male prisoners. They will initially be assessed on several measures of mood, social support and suicidality. They will then undergo therapy. Following this they will be asked to re-completed the initial measures and a post-therapy interview to ascertain their thoughts on their experience of the therapy.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 13 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The INSPiRe Programme: A Feasibility and Acceptability Study of Intensive Suicide Prevention Therapy in Prison
Actual Study Start Date : June 1, 2018
Actual Primary Completion Date : April 26, 2019
Actual Study Completion Date : April 26, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Suicide

Arm Intervention/treatment
Experimental: Intervention
10 hours of intensive CBT for suicide will be delivered to male prisoners who are having thoughts of ending their lives. This will be delivered in 2 hours sessions, 5 times across 2 weeks.
Other: INSPiRe Programme
Intensive CBT for suicide




Primary Outcome Measures :
  1. The Client Satisfaction Questionnaire (CSQ-8) [ Time Frame: 20 minutes ]
    A measure of participant satisfaction with therapy

  2. Therapist Session Summary [ Time Frame: 5 minutes ]
    Measuring levels of adherence and engagement

  3. Discharge summary sheet [ Time Frame: 15 minutes ]
    Capturing individuals' adherence to the programme or discharge from it

  4. Therapist Rating Form [ Time Frame: 20 minutes ]
    Giving an overall picture of each individual's engagement and progress during the study.

  5. Post-intervention interview [ Time Frame: 1 hour ]
    Qualitative interview to explore the participant's experience of therapy



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Gender Eligibility Description:   All participants will be recruited from a prison site that houses males.
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Aged over 21 years old.
  • Has been managed under the Assessment, Care in Custody, and Teamwork (ACCT) system within the last 1 month (including current ACCT review).
  • Sufficient English language proficiency, as judged by the researcher, in order to complete psychometric questionnaires (i.e. adequate reading comprehension) and engage in intensive CBT programme (i.e. adequate verbal communication).
  • Adult is able to provide informed consent as established during baseline clinical interview (BPS, 2006; MCA, 2005).
  • Currently residing in HM Prison (and expected to remain there for at least six weeks; determined through staff and prisoner report).

Exclusion Criteria:

  • A primary organic disorder (indicated by prison medical staff report or records).
  • Any current risk behaviour which would compromise the safety of others, as identified by prison staff.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03499548


Locations
Layout table for location information
United Kingdom
HMP Risley
Warrington, Greater Manchester, United Kingdom, WA3 6BP
Sponsors and Collaborators
University of Manchester
Investigators
Layout table for investigator information
Principal Investigator: Daniel Pratt University of Manchester
Study Chair: Yvonne Awenat University of Manchester
Study Chair: Charlotte Lennox University of Manchester

Layout table for additonal information
Responsible Party: Jessica Killilea, University of Manchester
ClinicalTrials.gov Identifier: NCT03499548    
Other Study ID Numbers: 238927
First Posted: April 17, 2018    Key Record Dates
Last Update Posted: August 12, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Jessica Killilea, University of Manchester:
Intensive
Cognitive Behavioral Therapy
Male prisoners
Additional relevant MeSH terms:
Layout table for MeSH terms
Suicide
Self-Injurious Behavior
Behavioral Symptoms